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Abstract 48 
Despite posing a significant public health threat, sleep disorders remain poorly understood 49 
and often mismanaged. Though seemingly unrelated, hand surgeons should be particularly 50 
mindful of sleep disorders, as numerous conditions of the upper extremity have known 51 
associations with sleep disturbances which can adversely affect patient outcomes, function 52 
and satisfaction. In addition, patients with sleep disorders are at significantly higher risk 53 
for severe, even life-threatening medical co-morbidities, further supporting the important 54 
role of hand surgeons in the recognition and management of sleep disorders that are most 55 
common in hand surgery. 56 
57 
Introduction 58 
Sleep disorders are a major public health concern, affecting as many as 70 million adults in 59 
the United States alone, while accounting for billions of dollars in financial costs, disability, 60 
and even death. [1-5] Sleep disorders are also associated with a myriad of medical 61 
conditions including obesity, hypertension, diabetes heart disease, and overall higher 62 
mortality risk. [6]  63 
 64 
Unfortunately, despite these exorbitant socioeconomic and health costs, sleep disorders are 65 
often overlooked or improperly treated. [7,8] In hand surgery, numerous conditions have 66 
known associations with sleep disorders, and sleep symptoms can directly affect patient 67 
outcomes, function and satisfaction. Thus, these disorders are important for hand surgeons 68 
to recognize and manage. The purpose of this review is to provide an overview of sleep 69 
disorders that are most common in hand surgery, with focus on the preoperative 70 
evaluation, and perioperative management of these disorders.   71 
 72 
 73 
Sleep Disorders in Hand Surgery 74 
This discussion will focus primarily on two classes of disorders most relevant to hand 75 
surgery: (1) dyssomnias which are disorders that produce excessive sleepiness or difficulty 76 
in initiating or maintaining sleep and (2) sleep disorders associated with other medical 77 
disorders. [9] A more inclusive outline of general sleep disorders is presented in Figure 1.  78 
 79 
Intrinsic Dyssomnias 80 
Intrinsic dyssomnias either (a) originate or develop within the body, or (b) arise 81 
from causes within the body. [9] This group includes psychological or medical disorders 82 
that produce a primary sleep disorder.   83 
 84 
Obstructive Sleep Apnea 85 
Perhaps the most widely recognized intrinsic dyssomnia in surgical patients is obstructive 86 
sleep apnea (OSA). Patients with OSA who are to undergo surgery require specialized 87 
management, as these patients are at higher risk for adverse events in the intraoperative 88 
and postoperative periods. In the perioperative setting, the primary concern is airway 89 
management; due to OSA patients’ decreased ability to protect their airway, procedures 90 
that would otherwise be performed under sedation may require monitored anesthesia care 91 
(MAC) or even general anesthesia for. [10,11] Ideally, open communication between the 92 
anesthesiologist and the hand surgeon allows these determinations to be made prior to the 93 
day of surgery, so as to minimize delays or complications.  94 
  95 
In addition to patients with a known diagnosis of OSA, surgeons are often tasked with 96 
caring for patients who lack a formal diagnosis, despite exhibiting clinical risk factors for 97 
OSA. [12] Chung et al reported an alarming 66% of patients lacking a preoperative OSA 98 
diagnosis with difficult intubations were confirmed to have OSA upon further evaluation. 99 
[13] Mutter et al found that those patients with undiagnosed OSA were at significantly 100 
higher risk of postoperative cardiac arrest than confirmed OSA patients, and that both 101 
groups faired worse than non-OSA patients. [14] These studies together point out the 102 
importance for the hand surgeon to recognize and screen for OSA, which can be done 103 
utilizing validated OSA screening methods, such as the STOP-Bang questionnaire (Table 1). 104 
Surgeons should also have a low threshold for referring patients with positive findings on 105 
OSA screening for further evaluation. [13,15] Postoperative management of OSA patients is 106 
also critical in avoiding morbidity, and OSA patients should resume continuous- or bilevel 107 
positive-airway-pressure (CPAP or BiPAP) treatment as soon as they are able. [15] 108 
Postoperative pain control regimens in OSA patients also merit special attention, which will 109 
be discussed shortly.  110 
 111 
Extrinsic Dyssomnias 112 
Extrinsic dyssomnias are those that originate or develop from causes outside of the body. 113 
[9] External factors are necessary to produce these disorders, and their removal is often 114 
therapeutic to the sleep disturbance. [9] In hand surgery, these most notably include both 115 
drug-induced and drug-dependant sleep disorders. 116 
 117 
Opioid-Induced Sleep Disorders 118 
A true understanding of the complex interplay of pain, opioid medication, and sleep 119 
disturbance remains elusive. Although evidence shows that pain and sleep exhibit a 120 
circular relationship with one another (i.e. pain causes sleep disturbance and sleep 121 
disturbance intensifies pain), [16-19] opioids used to concomitantly treat both pain and 122 
secondary sleep disorders are not always successful. [20,21]  123 
 124 
Opioid receptors in the brain are located in the same nuclei that are active in sleep 125 
regulation and abnormal sleep architecture has been reported as a characteristic feature of 126 
opioid use, with a reduction of rapid eye movement (REM), slow wave sleep stages, and 127 
overall sleep quality. [18,20,22] Opioid use in OSA patients can be particularly 128 
troublesome, as opioids not only impair arousal, but can worsen airway obstruction, even 129 
in non-OSA patients. [21,23,24] Thus, alternative multimodal pain management 130 
approaches are recommended to minimize the need for opioids for OSA patients. These 131 
include: regional or local anesthesia when appropriate, continuous peripheral nerve 132 
blockade, and non-opioid analgesics such as acetaminophen and NSAIDS. [15,23,25-27] 133 
Recent evidence also supports use of  low-dose ketamine or adjuvant clonidine injections 134 
to potentiate local or regional nerve blocks.  [23,28,29] Finally, conservative measures 135 
aimed at decreasing postoperative pain and inflammation such as icing, elevation, and 136 
compression should be emphasized, especially upon discharge home.  137 
 138 
Sedative-Dependent Sleep Disorders 139 
The use of short-acting sedative-hypnotics, particularly non-benzodiazepine sedative 140 
hypnotics (NBSH, e.g. zolpidem), for treatment of insomnia has increased markedly in 141 
recent decades. [30] Generally intended to treat short-term insomnia, NBSH 142 
discontinuation may precipitate rebound insomnia, lasting up to weeks in extreme cases, or 143 
after taking a single dose. [31-33] Thus, the dependency potential is relatively high. [34-36] 144 
Use of zolpidem as a postoperative sleep aid or pain-adjuvant has recently been described 145 
following knee and shoulder surgery with reported success in improving sleep quality and 146 
function, while decreasing opioid requirements, pain and fatigue. [37-39] However, none of 147 
these studies reported patient outcomes beyond the acute treatment period. [37-39] Its 148 
similar utility in hand surgery has not been reported. Perhaps surprisingly, antihistamines 149 
used as sleep aids may warrant similar caution. [41] A recent survey of patients who took 150 
the commonly-used sedative H1 antihistamine doxylamine found the majority of patients 151 
used the medication daily for at least six months, including 77% who experienced rebound 152 
insomnia when attempting to discontinue use. [41] These findings suggest that sedative 153 
hypnotics and antihistamines should be used with judiciously in hand surgery patients 154 
with sleep disorders. 155 
 156 
Sleep Disorders Associated with Mental, Neurologic, or Other Medical Disorders 157 
This second category includes a variety primary medical disorders that secondarily involve 158 
sleep disturbance or excessive sleepiness as a major clinical feature, [9] including several 159 
hand and upper extremity conditions.  160 
 161 
Carpal Tunnel Syndrome 162 
Insomnia is a nearly universal finding in patients with carpal tunnel syndrome (CTS), often 163 
serving as the primary motivating factor for seeking surgical care. [42-48] Although the 164 
mechanism linking these two conditions is unclear, McCabe and colleagues reported that 165 
patients with CTS are more likely to prefer sleeping on their side compared to control 166 
patients. [42-44] The authors acknowledge, however, that these associative findings do not 167 
necessary prove causation. In an effort to further characterize the severity of sleep 168 
disturbance in CTS patients, Patel et al prospectively studied patients with CTS and found 169 
that 78% of patients met the threshold for poor sleep quality using the Pittsburgh Sleep 170 
Quality Index (PSQI), a validated sleep-quality outcome measure. [46,49,50] The authors 171 
also noted a positive correlation between CTS-related functional impairment and severity 172 
of sleep symptoms. [46] The authors did not study the potential association of preoperative 173 
electrodiagnostic findings with sleep symptom severity, nor did they investigate the 174 
potential therapeutic effect of median nerve decompression on sleep symptoms. Both of  175 
these associations may warrant further study, as the ability to predict relief of sleep 176 
symptoms following decompressive surgery would allow clinicians to better tailor 177 
management for CTS patients whose primary complaints are sleep-related.    178 
 179 
Rheumatoid Arthritis and Other Inflammatory Arthropathies 180 
Sleep disturbances in patients with Rheumatoid Arthritis (RA) are multifactorial, 181 
codependent on pain, fatigue, and depression. [51-53] In a prospective analysis of RA 182 
patients seen at an outpatient clinic, Løppenthin et al reported that 61% met criteria for 183 
poor sleep using the PSQI. [52] Westhovens et al found that RA disease activity showed 184 
significantly positive correlation with worsening sleep symptoms, [53] while Fragiadaki et 185 
al reported improvement in sleep symptoms in a series of 15 RA patients treated with 186 
tocilizumab, [54] together suggesting that primary management of underlying RA activity 187 
may serve as an optimal strategy for co-managing sleep symptoms. Recent evidence has 188 
also demonstrated a significant association between psoriatic arthritis and sleep disorders, 189 
particularly OSA and insomnia. [55-58] Although etanercept was reported to improve 190 
insomnia symptoms in patients with psoriatic arthritis, treatment with adalimumab did not 191 
show a therapeutic effect on patients’ OSA symptoms. [57,58] Patients with both psoriatic 192 
arthritis and OSA who are to undergo hand surgery should be managed according to the 193 
OSA principles discussed earlier.  194 
 195 
 196 
Additional Management Considerations 197 
Given the potential adverse effects associated with sedatives and opioid pain medication, 198 
alternative treatment modalities for concomitant sleep disturbance and acute 199 
postoperative pain warrant further discussion. Gamma-aminobutyric acid (GABA) 200 
analogues gabapentin and pregabalin may have utility for treating concomitant pain and 201 
sleep symptoms, either as primary therapeutic or adjuvant agents. [59,60] Gabapentin has 202 
previously been shown as an effective treatment for both pain and sleep disturbance in CTS 203 
patients, [61] although this finding has been both supported and refuted in more recent 204 
studies. [62,63] Pregabalin shows promise in the concomitant treatment of sleep and pain 205 
symptoms, albeit in patients with fibromyalgia, for which it is FDA-approved. [64,65] While 206 
neither medication is currently FDA-approved for neuropathic pain associated specifically 207 
with conditions of the upper extremity, further investigation to that end could be 208 
worthwhile. [59] 209 
 210 
Another promising agent for use in hand surgery is exogenous melatonin. Although its 211 
sleep-promoting characteristics are widely-reported, melatonin possesses numerous  212 
additional benefits which suggest an ideal role as a therapeutic agent in hand surgery. [66] 213 
In vitro studies on chondrocytes demonstrate that melatonin is chondrogenic and 214 
promotes matrix synthesis, and can also serve as a rescue agent for chondrocytes that are 215 
exposed to damaging pro-inflammatory or cytotoxic factors. [67-69] In an animal model of 216 
median nerve injury, sleep deprivation made rats more vulnerable to nerve injury-induced 217 
neuropathic pain, while melatonin reversed nerve injury-induced hypersensitivity. [70] In 218 
the lone clinical study evaluating its efficacy in hand surgery, melatonin was found to 219 
improve tourniquet tolerance while decreasing opioid requirement in patients receiving 220 
regional anesthesia intravenously. [71] Given this therapeutic potential and limited 221 
adverse effect profile, use of melatonin in hand surgery certainly warrants ongoing trial 222 
and further investigation. 223 
 224 
 225 
Current Limitations and Future Directions  226 
Due to the complex interplay of sleep with pain, psychiatric disorders, social factors, and 227 
other associated conditions, the evaluation of sleep disorders in the hand surgery patient is 228 
rarely straightforward.  In a recent study by Peters and colleagues, the authors attempted 229 
to determine a relationship between sleep disturbance and upper-extremity disability, and 230 
found that psychological factors such as ineffective coping strategies were more likely to 231 
predict arm disability than sleep symptoms. [72] The authors discussed the possibility that 232 
sleep disturbance was also the product of these psychological factors, suggesting a 233 
bidirectional relationship. Their study exemplifies the challenging nature inherent to 234 
determining underlying pathology and causal relationships regarding sleep disturbances. 235 
This is echoed by Shulman et al, who found that sleep disturbance following distal radius 236 
fracture at long-term follow-up was more dependent on mental health than on functional 237 
status. [73]  238 
 239 
A second limitation of the current evidence regarding sleep disorders in hand surgery is 240 
with respect to the heterogeneity of the patient populations studied; a shortcoming fully 241 
acknowledged by Peters and colleagues. [72] In their study fractures, soft-tissue injuries, 242 
and degenerative conditions were all treated as equivalent upper extremity disabilities. 243 
Furthermore, CTS and cubital tunnel syndrome were lumped together although there is no 244 
current literature that describes sleep disorders in patients with cubital tunnel syndrome. 245 
Similarly, in their study of melatonin’s utility in improving tourniquet tolerance and 246 
decreasing opioid requirements, Mowafi and Ismail did not stratify or match patients based 247 
on condition or procedure. [71] Future studies using larger, more homogenous patient 248 
cohorts, would be critical to fully understanding the relationships between sleep disorders 249 
and hand pathologies, and developing precise and effective regimens to treat coexisting 250 
sleep and hand disease.  251 
 252 
 253 
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520 
Figure 1. Flow chart outlining the key types of sleep disorders relative to hand surgery in 521 
the context of a broader overview of all sleep disorder categories. The first level represents 522 
the three main categories of sleep disorders. Note that boxes in grey are not relevant to this 523 
discussion, those in red highlight the key types of sleep disorders known to be related to 524 
hand surgery patients, and those in purple represent conditions that are likely to be 525 
associated with sleep disorders based on current evidence.  526 
 527 
528 
 529 
Table 1. STOP-BANG Questionnaire to assess for risk of Obstructive Sleep Apnea (OSA). 530 
The first section (STOP) consists of four history or symptom-related questions for the 531 
patient to answer, while the second section (BANG) consists of four items that may be 532 
objectively measured by the clinician. Answers of “Yes” to any question or measure results 533 
in a point, while “No” does not result in a point. Patients with total scores of 0-2, 3-4 and 5-534 
8 points are considered low, intermediate, and high risk of having OSA, respectively.  535 
 536 
Question or Variable YES NO 
STOP   
Do you SNORE loudly  
(louder than talking or loud enough to be heard through closed doors)? 
1 0 
Do you often feel TIRED, fatigued, or sleepy during daytime? 1 0 
Has anyone OBSERVED you stop breathing during your sleep? 1 0 
Do you have or are you being treated for high blood PRESSURE? 1 0 
BANG   
BMI more than 35kg/m2? 1 0 
AGE over 50 years old? 1 0 
NECK circumference > 16 inches (40cm)? 1 0 
GENDER: Male? 1 0 
 537 
 538 
